Anti-miR-17 Therapy Delays Tumorigenesis in MYC-driven Hepatocellular Carcinoma (HCC)

Full text: Download

Publisher: Impact Journals

Preprint: policy unclear. Upload

Postprint: archiving forbidden. Upload

Published version: archiving allowed. Upload

Policy details (opens in a new window). Data provided by SHERPA/RoMEO